Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focus
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Nature
Nature Cell Biology
Nature Reviews Molecular Cell Biology
The EMBO Journal
Nature Reports Avian Flu
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
News and Views
Nature Structural Biology  9, 410 - 412 (2002)
doi:10.1038/nsb0602-410

Love it or cleave it: Tough choices in protein quality control

Michael R. Maurizi

Laboratory of Cell Biology, National Cancer Institute. Bethesda, Maryland 20892, USA.mmaurizi@helix.nih.gov

Housekeeping is not a humdrum process when it comes to protein quality control. Inside chaperone-protease machines, proteins are subject to dramatic life or death trials and must shape up rapidly to survive. Accumulation of aberrantly folded proteins is the basis of many diseases, so the outcome is vitally important to the cell.
Chaperone-protease machines have assumed a major position in the hierarchy of important biological molecules that are of interest to cell biologists, biochemists, and structural biologists. These complex proteins are associated with many fundamental processes required for the life of a cell. In addition, the molecules themselves have fascinating and intricate structural designs and mechanisms of action. Until recently the ATP-dependent molecular chaperone-protease machines, such as the proteasomes, the Clp proteases, Lon proteases and the membrane-associated FtsH/Yme1 proteases have received the most attention. Now, the crystal structures of two members of the DegP/HtrA protein family — the mammalian HtrA2/Omi, reported by Li et al.1 on page 436 of this issue of Nature Structural Biology and the Escherichia coli DegP/HtrA, reported by Krojer et al.2 in a recent issue of Nature — have broadened the focus to include a novel class of ATP-independent chaperone-proteases.

DegP is an essential protein in the E.coli periplasm. It protects cells by degrading damaged or denatured proteins generated during heat or chemical stress3. Such damaged proteins would otherwise form aggregates that are highly toxic to cells. DegP homologs in a number of pathogenic bacteria have been shown to be virulence factors, helping bacteria survive within the host cell in part by degrading periplasmic proteins damaged by the host's oxidative defense system4. Several years ago, Erhmann and colleagues5 reported an unusual property of E. coli DegP. At temperatures below 28 °C, DegP acts solely as a chaperone, protecting unfolded proteins from irreversible aggregation and increasing the yield of refolded protein. Above 28 °C, its protease activity increases dramatically and DegP efficiently degrades the unfolded proteins. Thus, DegP exhibits dual function and appears to combine chaperone activity with protease activity. While precedents exist for chaperone activity contributing to protein degradation, an important question is how this coupling is accomplished without the expenditure of energy. Equally puzzling are how proteolytic activity is suppressed at low temperature and what the nature of the molecular switch is that favors the degradative over the refolding pathway.

Interest in HtrA proteases was further stimulated by the discovery of mammalian homologs and their association with cellular stress responses6. Human HtrA1 is elevated in osteoarthritic cartilage7, whereas HtrA2 interacts with various IAPs (inhibitor of apoptosis proteins) and, when over-expressed, causes cell death8. The activity of XIAP, a mammalian caspase-9 inhibitor, is antagonized by, among other things, proteins such as Smac/DIABLO9, which is released from mitochondria in response to certain cell stress signals. Both Smac/DIABLO and HtrA2 specifically interact with IAPs through similar tetrapeptide motifs near their N-termini. HtrA2 must be proteolytically active to exert its killing effect, and, unlike the bacterial enzyme, it has proteolytic activity at both low and high temperatures. How HtrA2 proteolytic activity is regulated is not known.

HtrA subunits comprise a proteolytic domain and either one (HtrA2) or two (DegP) peptide-binding (PDZ) domains at the C-terminus. The crystal structures suggest that activities of HtrA2 and DegP derive from the interplay between two different structural features—the local environment of the proteolytic active site and the positions of the PDZ domains. Both proteases form trimers connected through their proteolytic domains. Trimer contacts are made through a narrow region near the N-terminus giving rise to a hollow pyramid-shaped particle with the active sites facing inward. Access to the active sites is restricted, identifying the HtrA family as a novel example of self-compartmentalized proteases10. In HtrA2, access is restricted by the PDZ domains, which rotate inward and form the base of the pyramid. In DegP, the native structure is actually a dimer of trimers joined by intertwined loops extending out from the base of the pyramid, thus forming a bipyramid with the active sites completely sequestered within (Fig. 1).

Figure 1. HtrA proteases from E. coli and from mammals use peptide-binding PDZ domains to screen appropriate substrates and to sweep unfolded proteins into the sequestered proteolytic chamber.
Figure 1 thumbnail

Mammalian HtrA2/Omi (top) has a single PDZ domain per subunit. In the oligomer, the PDZ domains block the active site until a substrate is encountered. Are activating receptors also used to facilitate the process by displacing the PDZ domains and exposing access channels to the active site chamber? In E. coli DegP/HtrA (bottom), tandem PDZ domains in each subunit are used to first bind substrates tightly at multiple sites. Rapid reciprocating movement of tentacular arms of PDZ domains would put stress on the protein and cause it to unfold. The home position of the PDZ domains aligns the peptide-binding grooves with the access channels and allows facile passage of the extended polypeptide into the interior chamber. There the protein is degraded, but when the protease is in an inactive state at low temperature, the unfolded protein is extruded instead and can refold. As a chaperone, DegP acts slowly on stoichiometric amounts of substrate and presumably uses thermal energy to tease the protein incrementally into a folding-competent form.



Full FigureFull Figure and legend (32K)
Another striking difference in the structures of HtrA2 and DegP is in the environments of their active sites. The proteolytic domains are typical of trypsin-like proteases with a classical Asp-His-Ser catalytic triad located in a crevice between two beta-barrel lobes. In HtrA2, the proteolytic active sites are in an active conformation poised for catalysis. In contrast, the active site of DegP is sterically blocked by a trio of loops from the surrounding protein, and the catalytic triad is distorted away from an active configuration. The major blocking loop is contributed by the symmetry-related subunit in the adjacent pyramid, suggesting that interaction of two trimers may be a significant factor in formation of the proteolytically inactive state of DegP.

A surprising aspect of the two structures is the apparent contradictory roles played by the PDZ domains. They appear to be the major element hindering access to the proteolytic active sites in HtrA2 but in DegP are poised to facilitate entry of substrates into the active site chamber (Fig. 1). PDZ domains are widespread and highly conserved protein interaction domains with a unique peptide-binding motif (GLGF or its conservative variations) that interacts with extended conformations of exposed C-terminal regions of proteins11. The domain contains predominantly beta-strands. The bound peptide is insinuated between a short helix and the edge of the adjacent beta-strand, completing the beta-sheet and adding to its stability. PDZ domains generally participate in assembly and organization of protein complexes, although in at least one other case, the bacterial tail-specific protease (Tsp) and its eukaryotic homolog, CtpA12, these domains are used to promote association between a protease and targeted protein substrates carrying C-terminal degradation tags.

Several lines of evidence suggest that the PDZ domains of HtrA2 play a dual role in its function. Because the active sites are sequestered in part by the protein interaction domain, it was reasonable to expect that removing the PDZ domain might allow unregulated proteolytic activity. Li et al.1 generated a mutant HtrA2 lacking the PDZ domain. This mutant has very high protease activity, and moreover is efficient at cell killing. Notably, monomeric forms of HtrA2 are proteolytically inactive, but removal of their PDZ domains restores the activity. On the basis of the requirement for a trimer and the need to displace the PDZ domain to activate protease activity, Li et al.1 speculated that trimeric HtrA2 might interact through its PDZ domains with a trimeric ligand, such as a cell death receptor, which displaces the PDZ domain and makes the active site chamber accessible to substrates.

What adds to the attractiveness of this model is the structure of DegP, which at first glance appears very different from HtrA2. Two different hexamers were found in the crystal of DegP, one in an 'open' and one in a 'closed' conformation. Both molecules are bipyramids connected through relatively narrow extended loops that form pillars separating the bases (Fig. 1). The access routes to the interior chamber lie between the pillars and can accommodate little more than secondary structure elements. The two PDZ domains per subunit do not impinge on the active site cleft but rather are splayed out from the base of the pyramid in each half of the particle and form mobile 'side walls'. In the closed conformation, interactions between pairs of the 12 PDZ domains completely block the entrances to the interior chamber. In the open conformation, the PDZ1 domains from opposite pyramids do not interact and their peptide binding grooves are positioned to shunt extended segments of substrates through the side openings into the active site chamber (Fig. 1).

The position of PDZ1 of DegP could well be a model for the position of the PDZ domain of HtrA2 upon activation by trimeric receptors. Interaction might both relieve inhibition and position the PDZ domains to facilitate the passage of substrates into the degradative chamber. Li et al.1 proposed that the activating receptor interacts with HtrA2 through the PDZ domain, which could put the receptor in competition with the substrate. An alternative model might be that receptor interaction occurs through another site in HtrA and, through an allosteric mechanism, causes the PDZ domains to adopt an active orientation, thus leaving the peptide-binding groove free for interaction with substrate. In any event, the mobility of the PDZ domains implied in the structure of DegP suggests that a domain-displacement model for activation of HtrA2 is quite feasible.

The mammalian enzyme does not appear to have chaperone activity independent of proteolytic activity, even at low temperature. The primary explanation for this appears to be the integrity of the proteolytic site, which is not blocked by a loop from another interacting trimer, as observed in the structure of DegP. In mammalian HtrA proteins, the major 'blocking loop' is shorter than that of the E. coli enzyme by 19 amino acids, thereby precluding its serving as a dimerization interface. Possibly, the shorter loop in the mammalian protein, which shares a number of conserved residues with its bacterial homolog, can have a regulatory effect within the trimer or interact with another protein.

The E. coli DegP appears to have three conformations: closed, open chaperone, and open protease. Because the proteolytic domains are virtually identical in both states, the transition between open and closed forms demonstrates the considerable flexibility of the hinge connecting the proteolytic and PDZ1 domains and the mobility of the PDZ2 domain. The function of the closed molecule, which appears inert because most of the binding sites are not accessible, is not known, but it is not believed to be the chaperone form. The structure of the open form in the crystal, with its non-functional proteolytic site, should represent the chaperone state. What conditions in addition to changes in temperature convert the protein between these states is of great interest. Krojer et al.2 noted that the conserved Arg 262 residue, which is positioned to interact with bound substrate, is located in the hinge between the protease and PDZ domains. Substrate binding could trigger movement of the PDZ domain and help favor the transition between states. Since, along with the carboxylate binding site, the -2 and -3 binding pockets in the PDZ domain dictate binding specificity, different substrates could impose this conformation switch with different efficiencies. Presumably a change in the trimer interface could alter the position of the major blocking loop, allowing reconfiguration of the catalytic triad.

Several aspects of the structures remain to be explained, and in particular the mechanism of coupling between peptide binding to the PDZ domain and either proteolytic activity or conformational switching remains to be elucidated. In HtrA2, a potentially inhibitory interaction is produced by the juxtapositioning of the loop between beta5 and beta6 with the peptide binding groove in the PDZ domain, which could exclude binding of substrates to that site. This interaction might stabilize an inactive conformation of the enzyme or could be involved in modulating substrate binding or release from the PDZ binding groove. Since the residues involved in binding are near the active site, their displacement by substrate could also have an activating effect on the protease. In E. coli DegP, a comparable function is proposed for a loop at the beginning of PDZ2, which interacts with its carboxylate binding groove. This interaction is postulated to facilitate displacement of substrate and to play a role in substrate translocation.

HtrA proteases act primarily on unfolded or misfolded proteins. The binding sites for the exposed hydrophobic regions of unfolded proteins are within the chamber, but the geometric constraints allow binding of an extended conformation only. The binding pockets of the PDZ domains are also hydrophobic, although they have greater specificity requirements and are generally more selective. Substrates must encounter the more specific exterior sites before gaining access to the less selective interior chamber. This situation is not unlike that in the Clp proteases or the proteasome, in which large ATPase complexes bind to the face of the proteolytic component and block random access to the entry channel, while at the same time providing binding sites for specific substrates and a means of actively translocating them inside. Kroger et al.2 speculate that the local and global fluidity of the PDZ domains, which results in continuous formation and dissolution of contacts with exposed regions of the unfolded protein substrates of DegP, would allow the protease to capture substrates and deliver them to the entrances to the inner cavity. From there the protein would be subject to further unfolding and either degradation or, for DegP at low temperature, release in a state favoring refolding. Now that the structural elements are in place, the exciting process of teasing the intricate processes of discrimination and decision making in the activity of these important and potentially lethal machines can begin in earnest.

 Top
REFERENCES
  1. Li, W. et al. Nature Struct. Biol. 9, 436−441 (2002). | Article | PubMed | ISI | ChemPort |
  2. Krojer, T. et al. Nature 416, 455−459 (2002). | Article | PubMed | ISI | ChemPort |
  3. Pallen, M.J. & Wren, B.W. Mol. Microbiol. 26, 209−221 (1997). | Article | PubMed | ISI | ChemPort |
  4. Pedersen, L.L. et al. Infect. Immun. 69, 2569−2579 (2001). | Article | PubMed | ISI | ChemPort |
  5. Spiess, C. et al. Cell 97, 339−347 (1999). | Article | PubMed | ISI | ChemPort |
  6. Gray, C.W. et al. Eur. J. Biochem. 267, 5699−5710 (2000). | Article | PubMed | ISI | ChemPort |
  7. Zumbrunn, J. & Trueb, B. FEBS Lett. 398, 87−92 (1996). | Article | PubMed |
  8. Suzuki, Y. et al. Mol. Cell. 8, 613−21 (2001). | Article | PubMed | ISI | ChemPort |
  9. Shi, Y. Nature Struct. Biol. 8, 394−401 (2001). | Article | PubMed | ISI | ChemPort |
  10. Lupas, A. et al. Trends in Biochem. Sci. 22, 399−404 (1997). | Article | ISI | ChemPort |
  11. Harris, B.Z. and Lim, W.A. J. Cell Sci. 114, 3219−31 (2001). | PubMed | ISI | ChemPort |
  12. Liao, D.I. et al. Nature Struct. Biol. 7, 749−753 (2000). | Article | PubMed | ISI | ChemPort |
 Top
FULL TEXT
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link
More articles like this

Open Innovation Challenges

Figures & Tables
References
See also: Letter by Li et al.
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Structural & Molecular Biology
ISSN: 1545-9993
EISSN: 1545-9985
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy